![]() |
市場調査レポート
商品コード
1306532
冠動脈バルーンカテーテルの世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore、タイプ別(PTCA、薬剤溶出、特殊バルーンカテーテル)Coronary Balloon Catheters Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedCore | Segmented by: Type (PTCA, Drug-Eluting & Speciality Balloon Catheter) |
||||||
適宜更新あり
|
冠動脈バルーンカテーテルの世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore、タイプ別(PTCA、薬剤溶出、特殊バルーンカテーテル) |
出版日: 2023年06月05日
発行: iData Research Inc.
ページ情報: 英文 43 Pages
納期: 即日から翌営業日
|
世界の冠動脈バルーンカテーテルの市場規模は、2022年に9億6,300万米ドルを超えました。同市場は今後、予測期間中に2.3%のCAGRで拡大し、2029年には11億米ドルを超えると予測されています。
当レポートでは、世界の冠動脈バルーンカテーテル市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。
In 2022, the global market for coronary balloon catheters exceeded a valuation of $963 million. Over the forecast period, it is projected to experience a compound annual growth rate (CAGR) of 2.3%, reaching a value exceeding $1.1 billion.
The comprehensive report suite encompasses the global market for coronary balloon catheters, which includes percutaneous transluminal coronary angioplasty (PTCA) balloons and specialty balloons. Specialty balloons encompass cutting and scoring balloons.
As part of our study on the global coronary balloon catheter market, iData Research has conducted a comprehensive analysis of angiography, angioplasty (or PCI), atherectomy, and catheterization procedure volumes. This analysis has been performed to enhance the accuracy of our market sizing and provide you with detailed information on procedure volumes spanning a 10-year timeframe across 70 countries. By incorporating procedure volume data, we aim to provide a comprehensive understanding of the market dynamics and trends in the coronary balloon catheter industry.
The primary purpose of coronary balloon catheters is to dilate a vessel before the insertion of a stent. The concerns surrounding late stent thrombosis have contributed to an increase in the number of pre-stent dilation procedures, thereby driving market growth. However, the widespread adoption of drug-eluting stents (DESs) has had a limiting impact on the coronary balloon catheter market. DESs have demonstrated effectiveness in reducing restenosis rates and minimizing the need for pre-stent dilation procedures. While coronary balloon catheters may still be used after DES procedures, the overall reduction in restenosis has resulted in a decrease in unit sales for both percutaneous transluminal coronary angioplasty (PTCA) and specialty balloon catheters.
Boston Scientific holds the top position in the global coronary balloon catheter market, with a strong presence in the percutaneous transluminal coronary angioplasty (PTCA) balloon segment, where it commands a majority share.
Philips entered the market by acquiring Spectranetics, establishing its position primarily in the specialty balloon catheter segment, where it has secured a significant market share.
Medtronic, like other major competitors in the global coronary balloon catheter market, offers a wide range of devices in both the coronary and peripheral markets. This allows the company to strategically bundle products and leverage its position in the competitive landscape.